Localization of CGRP receptor components, CGRP, and receptor binding sites in human and rhesus cerebellar cortex

Cerebellum

Volumn 12, Issue 6, 2013, Pages 937-949

  Eftekhari, Sajedeh ^a   Salvatore, Christopher A ^b   Gaspar, Renee C ^b   Roberts, Rhonda ^b   O'Malley, Stacey ^b   Zeng, Zhizhen ^b   Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cerebellum; CGRP; CLR; Nociception; Primate; RAMP1

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; COMPLEMENTARY DNA; MESSENGER RNA; PROCALCITONIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

ADOLESCENT; AGED; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING ASSAY; BINDING SITE; BRAIN MAPPING; CELLULAR DISTRIBUTION; CEREBELLUM CORTEX; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MALE; NEUROPHYSIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PURKINJE CELL; RECEPTOR BINDING; RHESUS MONKEY;

AGED; AGED, 80 AND OVER; ANIMALS; BINDING SITES; CALCITONIN GENE-RELATED PEPTIDE; CEREBELLAR CORTEX; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MACACA MULATTA; MALE; NERVE TISSUE PROTEINS; POSTMORTEM CHANGES; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 84892444332     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-013-0509-4     Document Type: Article

References (47)

1. Moulton EA, Schmahmann JD, Becerra L, Borsook D. The cerebellum and pain: passive integrator or active participator? Brain Res Rev. 2010;65:14-27.
2. Teune TM, van der Burg J, van der Moer J, Voogd J, Ruigrok TJ. Topography of cerebellar nuclear projections to the brain stem in the rat. Prog Brain Res. 2000;124:141-72.
3. Strick PL, Dum RP, Fiez JA. Cerebellum and nonmotor function. Annu Rev Neurosci. 2009;32:413-34.
4. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463-84.
5. Schmahmann JD. Frommovement to thought: anatomic substrates of the cerebellar contribution to cognitive processing. Hum Brain Mapp. 1996;4:174-98.
6. Edgley SA, Gallimore CM. The morphology and projections of dorsal horn spinocerebellar tract neurones in the cat. J Physiol. 1988;397:99-111.
7. Ekerot CF, Oscarsson O, Schouenborg J. Stimulation of cat cutaneous nociceptive C fibres causing tonic and synchronous activity in climbing fibres. J Physiol. 1987;386:539-46.
8. Ekerot CF, Gustavsson P, Oscarsson O, Schouenborg J. Climbing fibres projecting to cat cerebellar anterior lobe activated by cutaneous A and C fibres. J Physiol. 1987;386:529-38.
9. House E, Pansky B. A functional approach to neuroanatomy. New York: McGraw-Hill Book Company, Inc, New York; 1967
10. Jie W, Pei-Xi C. Discharge response of cerebellar Purkinje cells to stimulation of C-fiber in cat saphenous nerve. Brain Res. 1992;581:269-72.
11. Fields HL. Painmodulation: expectation, opioid analgesia and virtual pain. Prog Brain Res. 2000;122:245-53.
12. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658-60.
13. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet. 2001;357:1016-7.
14. Borsook D, Moulton EA, Tully S, Schmahmann JD, Becerra L. Human cerebellar responses to brush and heat stimuli in healthy and neuropathic pain subjects. Cerebellum. 2008;7:252-72.
15. Pietrobon D. Migraine: new molecular mechanisms. Neuroscientist. 2005;11:373-86.
16. Skofitsch G, Jacobowitz DM. Calcitonin gene-related peptide: detailed immunohistochemical distribution in the central nervous system. Peptides. 1985;6:721-45.
17. Hokfelt T, Arvidsson U, Ceccatelli S, Cortes R, Cullheim S, Dagerlind A, et al. Calcitonin gene-related peptide in the brain, spinal cord, and some peripheral systems. Ann N Y Acad Sci. 1992;657:119-34.
18. Bellamy JL, Cady RK, Durham PL. Salivary levels of CGRP andVIP in rhinosinusitis and migraine patients. Headache. 2006;46:24-33.
19. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33:48-56.
20. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor- like receptor. Nature. 1998;393:333-9.
21. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem. 2000;275:31438-43.
22. Zhang Z, Winborn CS, Marquez de Prado B, Russo AF. Sensitization of calcitonin gene-related peptide receptors by receptor activitymodifying protein-1 in the trigeminal ganglion. J Neurosci. 2007;27:2693-703.
23. Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights intomigraine pathophysiology. Nat Rev Neurol. 2010;6:573-82.
24. Edvinsson L, Eftekhari S, Salvatore CA, Warfvinge K. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat. Mol Cell Neurosci. 2010;46:333-9.
25. Hewitt DJ, Aurora SK, Dodick DW, Goadsby PJ, Ge YJ, Bachman R, et al. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia. 2011;31:712-22.
26. Salvatore CA, Moore EL, Calamari A, Cook JJ, Michener MS, O'Malley S, et al. Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist. J Pharmacol Exp Ther. 2010;333:152-60.
27. Paone DV, Nguyen DN, Shaw AW, Burgey CS, Potteiger CM, Deng JZ, et al. Orally bioavailable imidazoazepanes as calcitonin generelated peptide (CGRP) receptor antagonists: discovery ofMK-2918. Bioorg Med Chem Lett. 2011;21:2683-6.
28. Hershey JC, Corcoran HA, Baskin EP, Salvatore CA, Mosser S, Williams TM, et al. Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay. Regul Pept. 2005;127:71-7.
29. Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience. 2010;169:683-96.
30. Vincent M, Hadjikhani N. The cerebellum and migraine. Headache. 2007;47:820-33.
31. Saab CY, Willis WD. The cerebellum: organization, functions and its role in nociception. Brain Res Brain Res Rev. 2003;42:85-95.
32. Edvinsson L, Linde M. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet. 2010;376:645-55.
33. Helmchen C, Mohr C, Erdmann C, Petersen D, Nitschke MF. Differential cerebellar activation related to perceived pain intensity during noxious thermal stimulation in humans: a functional magnetic resonance imaging study. Neurosci Lett. 2003;335:202-6.
34. Helmchen C, Mohr C, Erdmann C, Binkofski F. Cerebellar neural responses related to actively and passively applied noxious thermal stimulation in human subjects: a parametric fMRI study. Neurosci Lett. 2004;361:237-40.
35. F.H. Maniyar TS, C. Schankin, T. Monteith, P.J. Goadsby. Investigating the premonitory phase of migraine with H2 150 PET. Cephalalgia 2013;33 Supplement
36. Sandor PS, Mascia A, Seidel L, de Pasqua V, Schoenen J. Subclinical cerebellar impairment in the common types of migraine: a threedimensional analysis of reaching movements. Ann Neurol. 2001;49:668-72.
37. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350:1104-10.
38. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008;372:2115-23.
39. Kawai Y, Takami K, Shiosaka S, Emson PC, Hillyard CJ, Girgis S, et al. Topographic localization of calcitonin gene-related peptide in the rat brain: an immunohistochemical analysis. Neuroscience. 1985;15:747-63.
40. Gregg KV, Bishop GA, King JS. Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex. J Neurocytol. 1999;28:431-8.
41. van Rossum D, Hanisch UK, Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev. 1997;21:649-78.
42. Morara S, Wimalawansa SJ, Rosina A. Monoclonal antibodies reveal expression of the CGRP receptor in Purkinje cells, interneurons and astrocytes of rat cerebellar cortex. Neuroreport. 1998;9:3755-9.
43. Briatore F, Patrizi A, Viltono L, Sassoe-Pognetto M, Wulff P. Quantitative organization of GABAergic synapses in the molecular layer of the mouse cerebellar cortex. PLoS One. 2010;5:e12119.
44. van Rossum D, Menard DP, Fournier A, St-Pierre S, Quirion R. Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain. J Pharmacol Exp Ther. 1994;270:779-87.
45. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience. 1994;62:553-67.
46. Morara S, Rosina A, Provini L, Forloni G, Caretti A, Wimalawansa SJ. Calcitonin gene-related peptide receptor expression in the neurons and glia of developing rat cerebellum: an autoradiographic and immunohistochemical analysis. Neuroscience. 2000;100:381-91.
47. D'Antoni S, Zambusi L, Codazzi F, Zacchetti D, Grohovaz F, Provini L, et al. Calcitonin gene-related peptide (CGRP) stimulates purkinje cell dendrite growth in culture. Neurochem Res. 2010;35:2135-43.